{"id":159608,"date":"2024-11-20T12:00:54","date_gmt":"2024-11-20T11:00:54","guid":{"rendered":"https:\/\/www.gpigroup.com\/news\/dawn-of-the-drug-cell\/"},"modified":"2024-11-20T12:00:54","modified_gmt":"2024-11-20T11:00:54","slug":"dawn-of-the-drug-cell","status":"publish","type":"post","link":"https:\/\/www.gpigroup.com\/en-uk\/news\/dawn-of-the-drug-cell\/","title":{"rendered":"Dawn of The Drug Cell"},"content":{"rendered":"<p><span style=\"font-weight: 400;\"><strong>The Drug Cell<\/strong> is born, a French Joint Venture poised to revolutionize the cell therapy sector. This groundbreaking project brings together technological and biotechnological excellence, including prominent companies, startups, universities, and leading research centers such as Carroucell, CECS\/I-Stem (Centre for Stem Cell Studies), CHU of Montpellier, CHU of Rennes, EFS (French Blood Establishment), EVerZom, MGA Technologies, and the University of Montpellier.\u00a0\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\"><strong>GPI France<\/strong>, a subsidiary of the GPI Group, will play a pivotal role in the project by leading the <strong>development of advanced in silico models powered by artificial intelligence<\/strong>. These models will automate the production of cell therapies, making treatments for rare diseases more accessible and cost-effective.\u00a0\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The project is set to launch in May 2025, with the first clinical trials planned for 2030 and market entry anticipated by 2034. It represents a long-term initiative with a profound social impact, aiming to <strong>establish an<\/strong> <strong>independent European industrial supply chain<\/strong> to address future healthcare challenges with cutting-edge solutions.\u00a0\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">As <strong>Sergio Manzana<\/strong>, future Chairman of The Drug Cell, explains: *\u201cThis project is a qualitative leap for GPI and a tangible response to the challenges of modern medicine. With The Drug Cell, we aim to improve people\u2019s quality of life and push the boundaries of biomedicine.\u201d*\u00a0\u00a0<\/span><\/p>\n<p><a href=\"https:\/\/www.gpigroup.com\/app\/uploads\/2024\/11\/024-11-20-Gpi-PR-The-Drug-Cell.pdf\"><strong>Read the full press release<\/strong><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Innovation and technology for a new cell therapy supply chain.<\/p>\n","protected":false},"author":38,"featured_media":159420,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2564,971],"tags":[],"class_list":["post-159608","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-investitori-en-uk","category-news-en-uk"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Dawn of The Drug Cell | GPI<\/title>\n<meta name=\"description\" content=\"Innovation and technology for a new cell therapy supply chain.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.gpigroup.com\/en-uk\/news\/dawn-of-the-drug-cell\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dawn of The Drug Cell | GPI\" \/>\n<meta property=\"og:description\" content=\"Innovation and technology for a new cell therapy supply chain.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.gpigroup.com\/en-uk\/news\/dawn-of-the-drug-cell\/\" \/>\n<meta property=\"og:site_name\" content=\"GPI\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/GruppoGPI\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-11-20T11:00:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.gpigroup.com\/app\/uploads\/2019\/04\/og-post-preview.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"4000\" \/>\n\t<meta property=\"og:image:height\" content=\"2342\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Federico Pessot\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Federico Pessot\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.gpigroup.com\\\/en-uk\\\/news\\\/dawn-of-the-drug-cell\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.gpigroup.com\\\/en-uk\\\/news\\\/dawn-of-the-drug-cell\\\/\"},\"author\":{\"name\":\"Federico Pessot\",\"@id\":\"https:\\\/\\\/www.gpigroup.com\\\/en-uk\\\/#\\\/schema\\\/person\\\/1f333989923a8e557c9d5ec39c78990f\"},\"headline\":\"Dawn of The Drug Cell\",\"datePublished\":\"2024-11-20T11:00:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.gpigroup.com\\\/en-uk\\\/news\\\/dawn-of-the-drug-cell\\\/\"},\"wordCount\":213,\"publisher\":{\"@id\":\"https:\\\/\\\/www.gpigroup.com\\\/en-uk\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.gpigroup.com\\\/en-uk\\\/news\\\/dawn-of-the-drug-cell\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.gpigroup.com\\\/app\\\/uploads\\\/2024\\\/11\\\/drug-cell-post-ENG.png\",\"articleSection\":[\"Investors\",\"News\"],\"inLanguage\":\"en-UK\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.gpigroup.com\\\/en-uk\\\/news\\\/dawn-of-the-drug-cell\\\/\",\"url\":\"https:\\\/\\\/www.gpigroup.com\\\/en-uk\\\/news\\\/dawn-of-the-drug-cell\\\/\",\"name\":\"Dawn of The Drug Cell | GPI\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.gpigroup.com\\\/en-uk\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.gpigroup.com\\\/en-uk\\\/news\\\/dawn-of-the-drug-cell\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.gpigroup.com\\\/en-uk\\\/news\\\/dawn-of-the-drug-cell\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.gpigroup.com\\\/app\\\/uploads\\\/2024\\\/11\\\/drug-cell-post-ENG.png\",\"datePublished\":\"2024-11-20T11:00:54+00:00\",\"description\":\"Innovation and technology for a new cell therapy supply chain.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.gpigroup.com\\\/en-uk\\\/news\\\/dawn-of-the-drug-cell\\\/#breadcrumb\"},\"inLanguage\":\"en-UK\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.gpigroup.com\\\/en-uk\\\/news\\\/dawn-of-the-drug-cell\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-UK\",\"@id\":\"https:\\\/\\\/www.gpigroup.com\\\/en-uk\\\/news\\\/dawn-of-the-drug-cell\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.gpigroup.com\\\/app\\\/uploads\\\/2024\\\/11\\\/drug-cell-post-ENG.png\",\"contentUrl\":\"https:\\\/\\\/www.gpigroup.com\\\/app\\\/uploads\\\/2024\\\/11\\\/drug-cell-post-ENG.png\",\"width\":1200,\"height\":1200,\"caption\":\"The Drug Cell - The revolution in cell therapies\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.gpigroup.com\\\/en-uk\\\/news\\\/dawn-of-the-drug-cell\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.gpigroup.com\\\/en-uk\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Dawn of The Drug Cell\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.gpigroup.com\\\/en-uk\\\/#website\",\"url\":\"https:\\\/\\\/www.gpigroup.com\\\/en-uk\\\/\",\"name\":\"GPI\",\"description\":\"The Healthcare Partner\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.gpigroup.com\\\/en-uk\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.gpigroup.com\\\/en-uk\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-UK\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.gpigroup.com\\\/en-uk\\\/#organization\",\"name\":\"GPI S.p.A.\",\"url\":\"https:\\\/\\\/www.gpigroup.com\\\/en-uk\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-UK\",\"@id\":\"https:\\\/\\\/www.gpigroup.com\\\/en-uk\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.gpigroup.com\\\/app\\\/uploads\\\/2023\\\/03\\\/logo-GPI-2019-1.jpg\",\"contentUrl\":\"https:\\\/\\\/www.gpigroup.com\\\/app\\\/uploads\\\/2023\\\/03\\\/logo-GPI-2019-1.jpg\",\"width\":1946,\"height\":1945,\"caption\":\"GPI S.p.A.\"},\"image\":{\"@id\":\"https:\\\/\\\/www.gpigroup.com\\\/en-uk\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/GruppoGPI\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/gpi-spa\",\"http:\\\/\\\/www.youtube.com\\\/user\\\/GruppoGPI\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.gpigroup.com\\\/en-uk\\\/#\\\/schema\\\/person\\\/1f333989923a8e557c9d5ec39c78990f\",\"name\":\"Federico Pessot\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-UK\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/01567a0a2e721b2e07509a56aef0c812074367509e3cd0488de6731c8be7c002?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/01567a0a2e721b2e07509a56aef0c812074367509e3cd0488de6731c8be7c002?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/01567a0a2e721b2e07509a56aef0c812074367509e3cd0488de6731c8be7c002?s=96&d=mm&r=g\",\"caption\":\"Federico Pessot\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Dawn of The Drug Cell | GPI","description":"Innovation and technology for a new cell therapy supply chain.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.gpigroup.com\/en-uk\/news\/dawn-of-the-drug-cell\/","og_locale":"en_US","og_type":"article","og_title":"Dawn of The Drug Cell | GPI","og_description":"Innovation and technology for a new cell therapy supply chain.","og_url":"https:\/\/www.gpigroup.com\/en-uk\/news\/dawn-of-the-drug-cell\/","og_site_name":"GPI","article_publisher":"https:\/\/www.facebook.com\/GruppoGPI\/","article_published_time":"2024-11-20T11:00:54+00:00","og_image":[{"width":4000,"height":2342,"url":"https:\/\/www.gpigroup.com\/app\/uploads\/2019\/04\/og-post-preview.jpg","type":"image\/jpeg"}],"author":"Federico Pessot","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Federico Pessot","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.gpigroup.com\/en-uk\/news\/dawn-of-the-drug-cell\/#article","isPartOf":{"@id":"https:\/\/www.gpigroup.com\/en-uk\/news\/dawn-of-the-drug-cell\/"},"author":{"name":"Federico Pessot","@id":"https:\/\/www.gpigroup.com\/en-uk\/#\/schema\/person\/1f333989923a8e557c9d5ec39c78990f"},"headline":"Dawn of The Drug Cell","datePublished":"2024-11-20T11:00:54+00:00","mainEntityOfPage":{"@id":"https:\/\/www.gpigroup.com\/en-uk\/news\/dawn-of-the-drug-cell\/"},"wordCount":213,"publisher":{"@id":"https:\/\/www.gpigroup.com\/en-uk\/#organization"},"image":{"@id":"https:\/\/www.gpigroup.com\/en-uk\/news\/dawn-of-the-drug-cell\/#primaryimage"},"thumbnailUrl":"https:\/\/www.gpigroup.com\/app\/uploads\/2024\/11\/drug-cell-post-ENG.png","articleSection":["Investors","News"],"inLanguage":"en-UK"},{"@type":"WebPage","@id":"https:\/\/www.gpigroup.com\/en-uk\/news\/dawn-of-the-drug-cell\/","url":"https:\/\/www.gpigroup.com\/en-uk\/news\/dawn-of-the-drug-cell\/","name":"Dawn of The Drug Cell | GPI","isPartOf":{"@id":"https:\/\/www.gpigroup.com\/en-uk\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.gpigroup.com\/en-uk\/news\/dawn-of-the-drug-cell\/#primaryimage"},"image":{"@id":"https:\/\/www.gpigroup.com\/en-uk\/news\/dawn-of-the-drug-cell\/#primaryimage"},"thumbnailUrl":"https:\/\/www.gpigroup.com\/app\/uploads\/2024\/11\/drug-cell-post-ENG.png","datePublished":"2024-11-20T11:00:54+00:00","description":"Innovation and technology for a new cell therapy supply chain.","breadcrumb":{"@id":"https:\/\/www.gpigroup.com\/en-uk\/news\/dawn-of-the-drug-cell\/#breadcrumb"},"inLanguage":"en-UK","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.gpigroup.com\/en-uk\/news\/dawn-of-the-drug-cell\/"]}]},{"@type":"ImageObject","inLanguage":"en-UK","@id":"https:\/\/www.gpigroup.com\/en-uk\/news\/dawn-of-the-drug-cell\/#primaryimage","url":"https:\/\/www.gpigroup.com\/app\/uploads\/2024\/11\/drug-cell-post-ENG.png","contentUrl":"https:\/\/www.gpigroup.com\/app\/uploads\/2024\/11\/drug-cell-post-ENG.png","width":1200,"height":1200,"caption":"The Drug Cell - The revolution in cell therapies"},{"@type":"BreadcrumbList","@id":"https:\/\/www.gpigroup.com\/en-uk\/news\/dawn-of-the-drug-cell\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.gpigroup.com\/en-uk\/"},{"@type":"ListItem","position":2,"name":"Dawn of The Drug Cell"}]},{"@type":"WebSite","@id":"https:\/\/www.gpigroup.com\/en-uk\/#website","url":"https:\/\/www.gpigroup.com\/en-uk\/","name":"GPI","description":"The Healthcare Partner","publisher":{"@id":"https:\/\/www.gpigroup.com\/en-uk\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.gpigroup.com\/en-uk\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-UK"},{"@type":"Organization","@id":"https:\/\/www.gpigroup.com\/en-uk\/#organization","name":"GPI S.p.A.","url":"https:\/\/www.gpigroup.com\/en-uk\/","logo":{"@type":"ImageObject","inLanguage":"en-UK","@id":"https:\/\/www.gpigroup.com\/en-uk\/#\/schema\/logo\/image\/","url":"https:\/\/www.gpigroup.com\/app\/uploads\/2023\/03\/logo-GPI-2019-1.jpg","contentUrl":"https:\/\/www.gpigroup.com\/app\/uploads\/2023\/03\/logo-GPI-2019-1.jpg","width":1946,"height":1945,"caption":"GPI S.p.A."},"image":{"@id":"https:\/\/www.gpigroup.com\/en-uk\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/GruppoGPI\/","https:\/\/www.linkedin.com\/company\/gpi-spa","http:\/\/www.youtube.com\/user\/GruppoGPI"]},{"@type":"Person","@id":"https:\/\/www.gpigroup.com\/en-uk\/#\/schema\/person\/1f333989923a8e557c9d5ec39c78990f","name":"Federico Pessot","image":{"@type":"ImageObject","inLanguage":"en-UK","@id":"https:\/\/secure.gravatar.com\/avatar\/01567a0a2e721b2e07509a56aef0c812074367509e3cd0488de6731c8be7c002?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/01567a0a2e721b2e07509a56aef0c812074367509e3cd0488de6731c8be7c002?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/01567a0a2e721b2e07509a56aef0c812074367509e3cd0488de6731c8be7c002?s=96&d=mm&r=g","caption":"Federico Pessot"}}]}},"_links":{"self":[{"href":"https:\/\/www.gpigroup.com\/en-uk\/wp-json\/wp\/v2\/posts\/159608","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.gpigroup.com\/en-uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.gpigroup.com\/en-uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.gpigroup.com\/en-uk\/wp-json\/wp\/v2\/users\/38"}],"replies":[{"embeddable":true,"href":"https:\/\/www.gpigroup.com\/en-uk\/wp-json\/wp\/v2\/comments?post=159608"}],"version-history":[{"count":0,"href":"https:\/\/www.gpigroup.com\/en-uk\/wp-json\/wp\/v2\/posts\/159608\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.gpigroup.com\/en-uk\/wp-json\/wp\/v2\/media\/159420"}],"wp:attachment":[{"href":"https:\/\/www.gpigroup.com\/en-uk\/wp-json\/wp\/v2\/media?parent=159608"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.gpigroup.com\/en-uk\/wp-json\/wp\/v2\/categories?post=159608"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.gpigroup.com\/en-uk\/wp-json\/wp\/v2\/tags?post=159608"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}